CIPH Ciphergen Biosystems (MM)

Ciphergen to Hold Conference Call Regarding Its Strategic Alliance With Quest Diagnostics FREMONT, Calif., July 22 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (CIPH) (NASDAQ:CIPH) announced that a conference call and webcast will be held on Monday, July 25 at 10 a.m. EDT to discuss the strategic alliance between Ciphergen Biosystems, Inc. and Quest Diagnostics Incorporated. The conference call and webcast are scheduled to begin at 10:00 a.m. EDT. To listen to the live webcast of the conference call, please visit the "Investors" section of the http://www.ciphergen.com/ web site. A telephonic replay of the conference call will be available two hours after the call and will be available until 11:59 p.m. on July 28. The replay number for domestic callers is 800-633-8284 and for international callers +1-402-977-9140. The passcode for both domestic and international callers is 21253397. In addition, an archived webcast of the conference call will be available under the "Investors" section of the company's website at http://www.ciphergen.com/. The webcast and replay are open to all interested parties, and will be available immediately on our website. About Ciphergen Ciphergen's Diagnostics Division is dedicated to the discovery of protein biomarkers and panels of biomarkers and their development into protein molecular diagnostic tests that improve patient care; and to providing collaborative R&D services through its Biomarker Discovery Centers(R) for biomarker discovery for new diagnostic tests as well as pharmacoproteomic services for improved drug toxicology, efficacy and theranostic assays. Ciphergen's Biosystems Division develops, manufactures and markets a family of ProteinChip(R) Systems and services for clinical, research, and process proteomics applications. ProteinChip Systems enable protein discovery, characterization, identification and assay development to provide researchers with predictive, multi-marker assay capabilities and a better understanding of biological function at the protein level. Additional information about Ciphergen can be found at http://www.ciphergen.com/. NOTE: Ciphergen, ProteinChip and Biomarker Discovery Center are registered trademarks of Ciphergen Biosystems, Inc. DATASOURCE: Ciphergen Biosystems, Inc. CONTACT: Sue Carruthers of Ciphergen Biosystems, Inc., Investor Relations, +1-510-505 2297 Web site: http://www.ciphergen.com/

Copyright